Status:
COMPLETED
Neural Mechanisms of Imaginal and in Vivo Exposure
Lead Sponsor:
Uppsala University
Conditions:
Fear of Spiders
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Imaginal exposure is a widely used and effective psychological treatment technique. Recent research suggests that neural activations and emotional responses during imaginal exposure are similar to tho...
Detailed Description
The study includes participants fearful of spiders and entails two experimental sessions, roughly one week apart. The first session includes brain imaging using functional magnetic resonance imaging (...
Eligibility Criteria
Inclusion
- Willing and able to provide informed consent and complete study procedures
- Fear of spiders
Exclusion
- Current psychiatric disorder other than spider phobia
- Current use of psychotropic medication
- Current neurological conditions
- MRI-contraindications (i.e metal implants in skull)
Key Trial Info
Start Date :
April 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT05193383
Start Date
April 7 2022
End Date
March 1 2023
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Swedish 7T facility
Lund, Sweden, 22242